Pharmaceuticals News and Research

RSS

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, today announced results from the EGALITY trial in which the primary endpoint of achieving equivalence in Psoriasis Area and Severity Index (PASI) 75 response rates at week 12 was met.

8 Jul 2016

Curza receives SBIR grant to develop new class of broad spectrum antibiotics

Curza Global, LLC, a company based on technology developed at the University of Utah, has been awarded a Phase I Small Business Innovation Research grant of $598,770 entitled "Natural product-inspired antibacterials with unique ribosomal binding" that will provide two years of support.

7 Jul 2016

New research shows how cholesterol medicine has beneficial effect on immune defence system

The cholesterol medicine simvastatin, which is one of the most commonly used pharmaceuticals in the world, also has a beneficial effect on the immune defence system with regard to diseases such as type 1 diabetes, multiple sclerosis and rheumatoid arthritis.

7 Jul 2016

PREVAIL IV trial opens in Liberia for EVD survivors with persistent traces of Ebola virus RNA

The Partnership for Research on Ebola Virus in Liberia, a U.S.-Liberia joint Clinical Research Partnership, today announced the opening of PREVAIL IV, a treatment trial for men who have survived Ebola virus disease (EVD) but continue to have evidence of Ebola virus genetic material, RNA, in their semen.

6 Jul 2016

MorphoSys receives clinical milestone for start of Phase 1 trial in prevention of thrombosis with novel antibody

MorphoSys AG announced that it has received a milestone payment from Novartis in connection with the initiation of a clinical phase 1 trial with a novel HuCAL antibody. The antibody will be tested in the field of prevention of thrombosis. This is the twelfth therapeutic antibody based on MorphoSys's technologies that Novartis is evaluating in clinical trials. Financial details were not disclosed.

6 Jul 2016

Alnylam reports new results from investigational RNAi therapeutic programs

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today preliminary results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, both investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of hereditary TTR-mediated amyloidosis (hATTR amyloidosis).

6 Jul 2016

Roche Diagnostics responds to HPV announcement

Roche Diagnostics welcomes the announcement by Public Health Minister, Jane Ellison, to introduce Human Papillomavirus (HPV) primary screening in England.

6 Jul 2016

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.

6 Jul 2016

Quantum Genomics initiates Phase IIa trial for heart failure

Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.

6 Jul 2016

Deutetrabenazine may help improve chorea symptoms in patients with HD

People with Huntington disease (HD) experienced improvements in chorea while taking deutetrabenazine (SD-809) compared to placebo, according to a paper published today in the Journal of the American Medical Association.

6 Jul 2016

Researchers demonstrate simple approach to prove how classes of new drugs work

A collaborative effort by cancer researchers at Cold Spring Harbor Laboratory and chemists at Boehringer Ingelheim, a pharmaceutical firm, has resulted in the identification of a new drug target in leukemia and creation of a candidate drug that hits the target.

6 Jul 2016

Celltrion Healthcare commits to develop lab tests for evidence-based decision-making in anti-TNF treatment

Celltrion Healthcare, a global biopharmaceutical company, today announced its research commitment to develop laboratory tests that will determine both drug and anti-drug antibody levels in the blood, enabling physicians to identify when patients on an anti-tumour necrosis factor drug require a change of dose or a switch to a different treatment in the class.

5 Jul 2016

SP Scientific provides one-source solution for pharmaceutical processing equipment

SP Scientific is now able to offer a one-source solution for a complete range of pharmaceutical processing equipment.

5 Jul 2016

Researchers uncover sensing mechanism of food poisoning bacteria found in shellfish

UT Southwestern Medical Center researchers have uncovered a mechanism that a type of pathogenic bacteria found in shellfish use to sense when they are in the human gut, where they release toxins that cause food poisoning.

5 Jul 2016

New test strip can rapidly, cost-effectively detect disease pathogens

At present, bacteria, fungi or viruses can generally only be detected with certainty by way of elaborate laboratory tests or animal experiments. The food and pharmaceutical industries would like to have faster tests to check their products.

4 Jul 2016

New report reveals commonly available chemicals endanger brain development in fetuses, children

In a new report, dozens of scientists, health practitioners and children's health advocates are calling for renewed attention to the growing evidence that many common and widely available chemicals endanger neurodevelopment in fetuses and children of all ages.

1 Jul 2016

Study focuses on critical proteins involved in ovarian cancer biology

In what is believed to be the largest study of its kind, scientists at the Pacific Northwest National Laboratory, Johns Hopkins University and their collaborators from institutions across the nation have examined the collections of proteins in the tumors of 169 ovarian cancer patients to identify critical proteins present in their tumors.

30 Jun 2016

New AAV 3.0 program to create next-generation viral vectors for better treatment of inherited diseases

The Perelman School of Medicine at the University of Pennsylvania has launched a new program, called AAV 3.0, to create new viral vectors to find quicker and better treatments for an array of diseases. James M. Wilson, MD, PhD, a professor of Medicine and director of the Orphan Disease Center, will lead an interdisciplinary team of over 30 scientists to create this new technology platform with support provided by the University of Pennsylvania Health System.

30 Jun 2016

Experts compile model list of essential diagnostic tests aiming to improve global health

In a western doctor's office or hospital, patients don't think twice about giving a blood or urine sample that can tell if they have a disease or infection, or show if their medicines are working. The samples get rushed to a testing lab with modern equipment that's held to high quality standards.

30 Jun 2016

Treatment for IBS proves difficult, survey reveals

A new national survey by Health Union of more than 1,000 individuals with Irritable Bowel Syndrome (IBS) reveals that the condition is difficult to diagnose and often even more difficult to treat.

29 Jun 2016

Pharmaceuticals News and Research

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

Curza receives SBIR grant to develop new class of broad spectrum antibiotics

New research shows how cholesterol medicine has beneficial effect on immune defence system

PREVAIL IV trial opens in Liberia for EVD survivors with persistent traces of Ebola virus RNA

MorphoSys receives clinical milestone for start of Phase 1 trial in prevention of thrombosis with novel antibody

Alnylam reports new results from investigational RNAi therapeutic programs

Roche Diagnostics responds to HPV announcement

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Quantum Genomics initiates Phase IIa trial for heart failure

Deutetrabenazine may help improve chorea symptoms in patients with HD

Researchers demonstrate simple approach to prove how classes of new drugs work

Celltrion Healthcare commits to develop lab tests for evidence-based decision-making in anti-TNF treatment

SP Scientific provides one-source solution for pharmaceutical processing equipment

Researchers uncover sensing mechanism of food poisoning bacteria found in shellfish

New test strip can rapidly, cost-effectively detect disease pathogens

New report reveals commonly available chemicals endanger brain development in fetuses, children

Study focuses on critical proteins involved in ovarian cancer biology

New AAV 3.0 program to create next-generation viral vectors for better treatment of inherited diseases

Experts compile model list of essential diagnostic tests aiming to improve global health

Treatment for IBS proves difficult, survey reveals

Industry Focus - Biopharma eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring